High-risk interim PET negative patients in Hodgkin's lymphoma.
LYSA Imaging, Department of Nuclear Medicine, Hôpital Henri Mondor, University Paris Est Créteil, Créteil, 94010, France. Electronic address: michel.meignan@aphp.fr.
Michel
M
Meignan
D019788:Fluorodeoxyglucose F18; D006689:Hodgkin Disease; D006801:Humans; D008223:Lymphoma; D008228:Lymphoma, Non-Hodgkin; D009364:Neoplasm Recurrence, Local; D049268:Positron-Emission Tomography; D011379:Prognosis; D012189:Retrospective Studies; D014057:Tomography, X-Ray Computed
D019788:Fluorodeoxyglucose F18